UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 232

Sortiert nach

ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

Annals of oncology, 2022-11, Vol.33 (11), p.1097-1118

2022

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte-predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experience

Annals of oncology, 2010-10, Vol.21 (10), p.2061-2068

2010

Link zum Volltext

Verfügbarkeit prüfen

UK Cancer Healthcare Professionals Collaborating With Colleagues in Low- and Middle-Income Countries: Mapping the Extent and Nature of Partnerships; Future Implications

Clinical oncology (Royal College of Radiologists (Great Britain)), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Platinum-based chemotherapy in triple-negative breast cancer

Annals of oncology, 2008-11, Vol.19 (11), p.1847-1852

2008

Link zum Volltext

Verfügbarkeit prüfen

Survival of women with inflammatory breast cancer: a large population-based study

Annals of oncology, 2014-06, Vol.25 (6), p.1143-1151

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma

Annals of oncology, 2008-07, Vol.19 (7), p.1312-1319

2008

Link zum Volltext

Verfügbarkeit prüfen

Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25–39 Years Old in the UK National Health Service

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-08, Vol.33 (8), p.494-506

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant therapy in locally advanced/borderline resectable gall bladder cancer

HPB (Oxford, England), 2016-04, Vol.18, p.e476-e476

2016

Link zum Volltext

Verfügbarkeit prüfen

A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-07, Vol.38 (1), p.47-51

2006

Link zum Volltext

Verfügbarkeit prüfen

The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma

Annals of oncology, 2007-03, Vol.18 (3), p.541-545

2007

Link zum Volltext

Verfügbarkeit prüfen

Multimodal approach and outcomes for borderline resectable pancreatic tumors

HPB (Oxford, England), 2016-04, Vol.18, p.e352-e353

2016

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy in gallbladder cancer – outcome of 112 patients from Tata Memorial Centre

HPB (Oxford, England), 2016-04, Vol.18, p.e52-e52

2016

Link zum Volltext

Verfügbarkeit prüfen

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

Annals of oncology, 2009-02, Vol.20 (2), p.244-250

2009

Link zum Volltext

Verfügbarkeit prüfen

The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract

British journal of cancer, 2007-04, Vol.96 (8), p.1178-1182

2007

Link zum Volltext

Verfügbarkeit prüfen

Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents

Annals of hematology, 2006-10, Vol.85 (10), p.671-679

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary Indian cancer center

Indian journal of cancer, 2015-07, Vol.52 (3), p.449

2015

Link zum Volltext

Verfügbarkeit prüfen

Liver directed therapies in management of colorectal liver metastasis (CRLM): Experience from Tata Memorial Centre

HPB (Oxford, England), 2016-04, Vol.18, p.e185-e185

2016

Link zum Volltext

Verfügbarkeit prüfen

Future challenges

Bone marrow transplantation (Basingstoke), 2007-12, Vol.40 (12), p.1157-1164

2007

Link zum Volltext

Verfügbarkeit prüfen

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants

Bone marrow transplantation (Basingstoke), 2005-03, Vol.35 (6), p.609-617

2005

Link zum Volltext

Verfügbarkeit prüfen

P50.08 Targeting HER2 or EGFR Exon 20 Insertion Mutation in Lung Cancer - A Case Series from India

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1117-S1117

2021

Link zum Volltext

Verfügbarkeit prüfen

429P Cancer and COVID-19 in India: Assessing the impact in a nationwide survey

Annals of oncology, 2022-11, Vol.33, p.S1608-S1608

2022

Link zum Volltext

Verfügbarkeit prüfen

Multiple myeloma

The Lancet (British edition), 2004-03, Vol.363 (9412), p.875-887

2004

Link zum Volltext

Verfügbarkeit prüfen

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

Bone marrow transplantation (Basingstoke), 2002-11, Vol.30 (10), p.673-679

2002

Link zum Volltext

Verfügbarkeit prüfen

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon- alpha 2b in patients with multiple myeloma maintained on a steady dose of interferon- alpha 2b

Annals of oncology, 2007-08, Vol.18 (8), p.1388-1394

2007

Link zum Volltext

Verfügbarkeit prüfen

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-α2b in patients with multiple myeloma maintained on a steady dose of interferon-α2b

Annals of oncology, 2007-08, Vol.18 (8), p.1388-1394

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(221)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

Lymphocyte-predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experience

UK Cancer Healthcare Professionals Collaborating With Colleagues in Low- and Middle-Income Countries: Mapping the Extent and Nature of Partnerships; Future Implications

Platinum-based chemotherapy in triple-negative breast cancer

Survival of women with inflammatory breast cancer: a large population-based study

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma

Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25–39 Years Old in the UK National Health Service

Neoadjuvant therapy in locally advanced/borderline resectable gall bladder cancer

A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation

The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma

Multimodal approach and outcomes for borderline resectable pancreatic tumors

Neoadjuvant chemotherapy in gallbladder cancer – outcome of 112 patients from Tata Memorial Centre

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract

Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents

Treatment of patients with metastatic pancreatic cancer: Experience from a tertiary Indian cancer center

Liver directed therapies in management of colorectal liver metastasis (CRLM): Experience from Tata Memorial Centre

Future challenges

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants

P50.08 Targeting HER2 or EGFR Exon 20 Insertion Mutation in Lung Cancer - A Case Series from India

429P Cancer and COVID-19 in India: Assessing the impact in a nationwide survey

Multiple myeloma

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon- alpha 2b in patients with multiple myeloma maintained on a steady dose of interferon- alpha 2b

An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-α2b in patients with multiple myeloma maintained on a steady dose of interferon-α2b

Suchergebnisse filtern